Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    -6.50 (-5.42%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Trading Update

22 Jan 2025 07:00

RNS Number : 1951U
Itaconix PLC
22 January 2025
 

For release on RNS: 22 January 2025

Itaconix plc

("Itaconix", the "Company" or the "Group")

Trading Update

Itaconix plc (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used to decarbonize everyday consumer products, is pleased to provide a trading update for the year ended 31 December 2024 which is in line with expectations.

Unaudited 2024 revenues of $6.5 million and an increase in unaudited gross profit margins to c. 35% from 31% in 2023. reflect the Company's success at adjusting market positioning in 2024. Revenue diversification has also improved significantly, with increased contributions from a wider array of products across a broader customer base. The Board believes the Company is well positioned for future revenue growth as a higher margin business, in furtherance of the Board's strategy to become a profitable specialty ingredient company.

The Cleaning Sector remains a key strength and leading source of revenue. European volumes continue to grow significantly as more detergent formulators and producers recognize the superior performance, cost efficiency, and sustainability benefits of Itaconix's plant-based detergent polymers. This growth partially offset the anticipated year-on-year ("y-o-y") decline in the North American Cleaning Sector as a result of the previously announced strategic move away from a low margin customer.

Increased volumes purchased by Croda and Nouryon led to sizable y-o-y revenue growth in the Hygiene and Beauty Sectors, respectively. The high relative value of Itaconix's odour neutralizing and hair styling ingredients contributed to improving the Company's overall gross profit margin.

The size and breadth of the Formulated Solutions business segment continue to grow. The Company is increasingly able to provide North American brands with new generations of consumer products. The SPARX™ program, aimed at fostering collaborative innovation with advanced specialty ingredient companies and end-product manufacturers, is developing well and is expected to introduce at least 10 new products and generate additional revenue opportunities in 2025.

The balance sheet remains strong with sufficient cash resources to fund future growth. Unaudited net cash and investments as at 31 December 2024 were $6.7 million (2023: $10.0 million), which reflects investments in new marketing capabilities, new products, additional product studies and global regulatory approvals as well as a step up in inventory levels to support substantial current and expected increases in European revenues.

Itaconix is proud of its Environmental, Social, and Governance (ESG) impact and its 2023 ESG report is available for investors to review on the Company website. Visit www.itaconix.com to download the report.

Overall, the Board remains optimistic about the Company's prospects for 2025, driven by increasing customer and consumer awareness of the efficacy, cost benefits, and sustainability of its products. The new year has started strongly, although the Board remains mindful of current macroeconomic and geopolitical risks, including a potential for increased tariffs on key raw materials that the Company sources from Asia.

Further details of 2024 trading and the latest outlook for 2025 will be provided when the Company announces FY24 results by early April.

John R. Shaw, CEO of Itaconix, commented:

"We have ended 2024 in a strong position, with trading in line with expectations and continued progress in diversifying our revenues. Our growth in Europe, customer diversification, and the development of our SPARX™ program underpin our optimism for 2025. We remain committed to delivering sustainable solutions that meet evolving customer needs while carefully navigating external risks. With a solid balance sheet and a growing customer base, we are confident in our ability to sustain growth and create long-term value."

- Ends -

Enquiries:

Itaconix plc +1 603 775 4400

John R. Shaw / Laura Denner

Rosewood +44 (0) 207 653 8704

Financial PR

John West / Llew Angus

Canaccord Genuity +44 (0) 7523 8000

Nominated Adviser and Broker

Adam James / Harry Pardoe

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's products contribute to the global low carbon economy.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDBGDBIUDDGUB
Date   Source Headline
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
22nd Aug 20237:00 amRNSShare Consolidation & Total Voting Rights
15th Aug 20237:00 amRNSShare Consolidation
12th Jul 20237:00 amRNSTrading Update
28th Jun 202312:29 pmRNSAGM Statement
5th Jun 20237:00 amRNSFinal Results
24th May 20237:00 amRNSNotice of Final Results, Briefings, and AGM
25th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
2nd Mar 20233:25 pmRNSTR-1
1st Mar 20237:00 amRNSAward from Frost & Sullivan
28th Feb 20236:03 pmRNSTR-1
28th Feb 20235:04 pmRNSTR-1
28th Feb 20233:09 pmRNSTR-1
23rd Feb 20237:00 amRNSTR-1
22nd Feb 202312:28 pmRNSResults of Open Offer, GM and Total Voting Rights
15th Feb 20237:00 amRNSInvestor Presentation following GM on 22 Feb 2023
3rd Feb 20237:00 amRNSPlacing, Subscription and Open Offer; Notice of GM
5th Jan 20237:00 amRNSBoard Change
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20227:00 amRNSItaconix and Brenntag Promote Sustainable Cleaning
14th Sep 20227:00 amRNSHalf year results
13th Sep 202211:05 amRNSSecond Price Monitoring Extn
13th Sep 202211:00 amRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSItaconix and Croda Renew Supply Agreement
20th Jul 20227:00 amRNSBoard Change
13th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSDirectorate Change
1st Jul 20222:37 pmRNSResult of AGM
1st Jul 20229:00 amRNSPrice Monitoring Extension
1st Jul 20227:00 amRNSAGM Statement and Notice of Capital Markets Event
29th Jun 20227:00 amRNSNotice of Capital Markets Webinar
8th Jun 20229:04 amRNSFinal Results - replacement
8th Jun 20227:30 amRNSTR-1
8th Jun 20227:00 amRNSFinal Results
6th Jun 20222:00 pmRNSPrice Monitoring Extension
27th May 20227:00 amRNSNotice of Final Results, Presentation and AGM
22nd Apr 20227:00 amRNSNew Funding to Support EU Volumes
20th Apr 20227:00 amRNSTrading Update
19th Apr 20227:00 amRNSBoard Changes
29th Mar 202211:05 amRNSSecond Price Monitoring Extn
29th Mar 202211:00 amRNSPrice Monitoring Extension
22nd Feb 20224:41 pmRNSSecond Price Monitoring Extn
22nd Feb 20224:35 pmRNSPrice Monitoring Extension
16th Feb 20224:41 pmRNSSecond Price Monitoring Extn
16th Feb 20224:36 pmRNSPrice Monitoring Extension
16th Feb 20227:00 amRNSInvestor Event
9th Feb 202211:06 amRNSSecond Price Monitoring Extn
9th Feb 202211:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.